Monocytes from cystic fibrosis patients are locked in an LPS tolerance state: Down-regulation of TREM-1 as putative underlying mechanism

PLoS ONE

Volumn 3, Issue 7, 2008, Pages

  del Fresno, Carlos ^a   Gómez Piña, Vanesa ^a   Lores, Vanesa ^a   Soares Schanoski, Alessandra ^a   Fernández Ruiz, Irene ^a   Rojo, Blas ^a   Alvarez Sala, Rodolfo ^a   Caballero Garrido, Ernesto ^a   García, Felipe ^b   Veliz, Tania ^c   Arnalich, Francisco ^d   Fuentes Prior, Pablo ^e   García Rio, Francisco ^a   López Collazo, Eduardo ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b Discover Unit   (Spain)

^c Unit di Ecocardiografia Applicata   (Italy)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^e HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIBIOTIC AGENT; BRONCHODILATING AGENT; BUDESONIDE; ENDOTOXIN; FLUTICASONE; FORMOTEROL; IPRATROPIUM BROMIDE; LIPOPOLYSACCHARIDE; NEOMYCIN; OXYGEN; PROSTAGLANDIN E2; RNA; SALBUTAMOL; SALMETEROL; SYNAPTOTAGMIN I; THEOPHYLLINE; TIOTROPIUM BROMIDE; TOBRAMYCIN; TOLL LIKE RECEPTOR; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; TREM1 PROTEIN, HUMAN;

ADULT; AGED; ANIMAL CELL CULTURE; ARTICLE; CELL ISOLATION; CELL NUCLEUS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE TRANSLOCATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MONOCYTE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN ISOLATION; RNA ISOLATION; UPREGULATION; VOLUNTEER; WESTERN BLOTTING; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; CELL SEPARATION; CYTOLOGY; LUNG; METABOLISM; MICROBIOLOGY;

ADULT; AGED; CASE-CONTROL STUDIES; CELL SEPARATION; CYSTIC FIBROSIS; DINOPROSTONE; DOWN-REGULATION; ENDOTOXINS; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; LUNG; MALE; MEMBRANE GLYCOPROTEINS; MONOCYTES; RECEPTORS, IMMUNOLOGIC;

EID: 50549102070     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002667     Document Type: Article

References (59)

1. Rowe SM, Miller S, Sorscher EJ (2005) Cystic fibrosis. N Engl J Med 352: 1992-2001.
2. Gadsby DC, Vergani P, Csanady L (2006) The ABC protein turned chloride channel whose failure causes cystic fibrosis. Nature 440: 477-483.
3. Ratjen F, Doring G (2003) Cystic fibrosis. Lancet 361: 681-689.
4. Sibley CD, Rabin H, Surette MG (2006) Cystic fibrosis: a polymicrobial infectious disease. Future Microbiol 1: 53-61.
5. Ramsey BW (1996) Management of pulmonary disease in patients with cystic fibrosis. N Engl J Med 335: 179-188.
6. Bouchon A, Dietrich J, Colonna M (2000) Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 164: 4991-4995.
7. Klesney-Tait J, Turnbull IR, Colonna M (2006) The TREM receptor family and signal integration. Nat Immunol 7: 1266-1273.
8. Knapp S, Gibot S, de Vos A, Versteeg HH, Colonna M, et al. (2004) Cutting edge: expression patterns of surface and soluble triggering receptor expressed on myeloid cells-1 in human endotoxemia. J Immunol 173: 7131-7134.
9. Gomez-Pina V, Soares-Schanoski A, Rodriguez-Rojas A, Del Fresno C, Garcia F, et al. (2007) Metalloproteinases shed TREM-1 ectodomain from lipopolysaccharide-stimulated human monocytes. J Immunol 179: 4065-4073.
10. Gibot S, Massin F, Marcou M, Taylor V, Stidwill R, et al. (2007) TREM-1 promotes survival during septic shock in mice. Eur J Immunol 37: 456-466.
11. Haselmayer P, Grosse-Hovest L, von Landenberg P, Schild H, Radsak MP (2007) TREM-1 ligand expression on platelets enhances neutrophil activation. Blood 110: 1029-1035.
12. Mohamadzadeh M, Coberley SS, Olinger GG, Kalina WV, Ruthel G, et al. (2006) Activation of triggering receptor expressed on myeloid cells-1 on human neutrophils by marburg and ebola viruses. J Virol 80: 7235-7244.
13. Murakami Y, Kohsaka H, Kitasato H, Akahoshi T (2007) Lipopolysaccharide-induced up-regulation of triggering receptor expressed on myeloid cells-1 expression on macrophages is regulated by endogenous prostaglandin E2. J Immunol 178: 1144-1150.
14. Tejera A, Santolaria F, Diez ML, Aleman-Valls MR, Gonzalez-Reimers E, et al. (2007) Prognosis of community acquired pneumonia (CAP): value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response. Cytokine 38: 117-123.
15. Gibot S, Cravoisy A, Kolopp-Sarda MN, Bene MC, Faure G, et al. (2005) Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis. Crit Care Med 33: 792-796.
16. Gibot S, Kolopp-Sarda MN, Bene MC, Bollaert PE, Lozniewski A, et al. (2004) A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J Exp Med 200: 1419-1426.
17. Determann RM, Millo JL, Gibot S, Korevaar JC, Vroom MB, et al. (2005) Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia. Intensive Care Med 31: 1495-1500.
18. Gibot S, Cravoisy A, Dupays R, Barraud D, Nace L, et al. (2007) Combined measurement of procalcitonin and soluble TREM-1 in the diagnosis of nosocomial sepsis. Scand J Infect Dis 39: 604-608.
19. Gibot S, Cravoisy A (2004) Soluble form of the triggering receptor expressed on myeloid cells-1 as a marker of microbial infection. Clin Med Res 2: 181-187.
20. Horonenko G, Hoyt JC, Robbins RA, Singarajah CU, Umar A, et al. (2007) Soluble triggering receptor expressed on myeloid cell-1 is increased in patients with ventilator-associated pneumonia: a preliminary report. Chest 132: 58-63.
21. Liu CL, Hsieh WY, Wu CL, Kuo HT, Lu YT (2007) Triggering receptor expressed on myeloid cells-1 in pleural effusions: a marker of inflammatory disease. Respir Med 101: 903-909.
22. How CK, Chern CH, Wu MF, Wang LM, Huang CI, et al. (2007) Expression of the triggering receptor expressed on myeloid cells-1 mRNA in a heterogeneous infected population. Int J Clin Pract.
23. Rosenstein BJ, Cutting GR (1998) The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr 132: 589-595.
24. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS (2001) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 163: 1256-1276.
25. Mahler DA, Wells CK (1988) Evaluation of clinical methods for rating dyspnea. Chest 93: 580-586.
26. Celli BR, MacNee W (2004) Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23: 932-946.
27. Escoll P, del Fresno C, Garcia L, Valles G, Lendinez MJ, et al. (2003) Rapid up-regulation of IRAK-M expression following a second endotoxin challenge in human monocytes and in monocytes isolated from septic patients. Biochem Biophys Res Commun 311: 465-472.
28. del Fresno C, Otero K, Gomez-Garcia L, Gonzalez-Leon MC, Soler-Ranger L, et al. (2005) Tumor cells deactivate human monocytes by up-regulating IL-1 receptor associated kinase-M expression via CD44 and TLR4. J Immunol 174: 3032-3040.
29. Lopez-Collazo E, Hortelano S, Rojas A, Bosca L (1998) Triggering of peritoneal macrophages with IFN-alpha/beta attenuates the expression of inducible nitric oxide synthase through a decrease in NF-kappaB activation. J Immunol 160: 2889-2895.
30. Govan JR, Brown AR, Jones AM (2007) Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection. Future Microbiol 2: 153-164.
31. Saiman L, Siegel J (2004) Infection control in cystic fibrosis. Clin Microbiol Rev 17: 57-71.
32. Kim HM, Park BS, Kim JI, Kim SE, Lee J, et al. (2007) Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 130: 906-917.
33. del Fresno C, Soler-Rangel L, Soares-Schanoski A, Gomez-Pina V, Gonzalez-Leon MC, et al. (2007) Inflammatory responses associated with acute coronary syndrome up-regulate IRAK-M and induce endotoxin tolerance in circulating monocytes. J Endotoxin Res 13: 39-52.
34. Kobayashi K, Hernandez LD, Galan JE, Janeway CA Jr, Medzhitov R, et al. (2002) IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110: 191-202.
35. Lopez-Collazo E, Fuentes-Prior P, Arnalich F, del Fresno C (2006) Pathophysiology of interleukin-1 receptor-associated kinase-M: implications in refractory state. Curr Opin Infect Dis 19: 237-244.
36. Gibot S, Cravoisy A, Levy B, Bene MC, Faure G, et al. (2004) Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med 350: 451-458.
37. Richeldi L, Mariani M, Losi M, Maselli F, Corbetta L, et al. (2004) Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections. Eur Respir J 24: 247-250.
38. Gibot S, Alauzet C, Massin F, Sennoune N, Faure GC, et al. (2006) Modulation of the triggering receptor expressed on myeloid cells-1 pathway during pneumonia in rats. J Infect Dis 194: 975-983.
39. Gibot S (2006) The therapeutic potential of TREM-1 modulation in the treatment of sepsis and beyond. Curr Opin Investig Drugs 7: 438-442.
40. Zeng H, Ornatowska M, Joo MS, Sadikot RT (2007) TREM-1 expression in macrophages is regulated at transcriptional level by NF-kappaB and PU.1. Eur J Immunol 37: 2300-2308.
41. DeKoter RP, Kamath MB, Houston IB (2007) Analysis of concentration-dependent functions of PU.1 in hematopoiesis using mouse models. Blood Cells Mol Dis 39: 316-320.
42. Norman D, Elborn JS, Cordon SM, Rayner RJ, Wiseman MS, et al. (1991) Plasma tumour necrosis factor alpha in cystic fibrosis. Thorax 46: 91-95.
43. Elborn JS, Norman D, Delamere FM, Shale DJ (1992) In vitro tumor necrosis factor-alpha secretion by monocytes from patients with cystic fibrosis. Am J Respir Cell Mol Biol 6: 207-211.
44. Jaresova J, Rozkova D, Spisek R, Janda A, Brazova J, et al. (2007) Kinetics of Toll-like receptor-4 splice variants expression in lipopolysaccharide-stimulated antigen presenting cells of healthy donors and patients with cystic fibrosis. Microbes Infect 9: 1359-1367.
45. Massengale AR, Quinn F Jr, Yankaskas J, Weissman D, McClellan WT, et al. (1999) Reduced interleukin-8 production by cystic fibrosis airway epithelial cells. Am J Respir Cell Mol Biol 20: 1073-1080.
46. Hartl D, Latzin P, Hordijk P, Marcos V, Rudolph C, et al. (2007) Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease. Nat Med 13: 1423-1430.
47. Muir A, Soong G, Sokol S, Reddy B, Gomez MI, et al. (2004) Toll-like receptors in normal and cystic fibrosis airway epithelial cells. Am J Respir Cell Mol Biol 30: 777-783.
48. Dehus O, Hartung T, Hermann C (2006) Endotoxin evaluation of eleven lipopolysaccharides by whole blood assay does not always correlate with Limulus amebocyte lysate assay. J Endotoxin Res 12: 171-180.
49. Radsak MP, Taube C, Haselmayer P, Tenzer S, Salih HR, et al. (2007) Soluble triggering receptor expressed on myeloid cells 1 is released in patients with stable chronic obstructive pulmonary disease. Clin Dev Immunol 2007: 52040.
50. Xu Y, Clark JC, Aronow BJ, Dey CR, Liu C, et al. (2003) Transcriptional adaptation to cystic fibrosis transmembrane conductance regulator deficiency. J Biol Chem 278: 7674-7682.
51. Dorin JR, Novak M, Hill RE, Brock DJ, Secher DS, et al. (1987) A clue to the basic defect in cystic fibrosis from cloning the CF antigen gene. Nature 326: 614-617.
52. Wilkinson MM, Busuttil A, Hayward C, Brock DJ, Dorin JR, et al. (1988) Expression pattern of two related cystic fibrosis-associated calcium-binding proteins in normal and abnormal tissues. J Cell Sci 91 (Pt 2): 221-230.
53. Yang Z, Wara-Aswapati N, Chen C, Tsukada J, Aaron PE (2000) NF-IL6 (C/ EBPbeta-) vigorously activates il1b gene expression via a Spi-1 (PU.1) protein-protein tether. J Biol Chem 275: 21272-21277.
54. Mouri F, Tsukada J, Mizobe T, Higashi T, Yoshida Y, et al. (2008) Intracellular HMGB1 transactivates the human IL1B gene promoter through association with an Ets transcription factor PU.1. Eur J Haematol 80: 10-19.
55. Lichanska AM, Browne CM, Henkel GW, Murphy KM, Ostrowski MC, et al. (1999) Differentiation of the mononuclear phagocyte system during mouse embryogenesis: the role of transcription factor PU.1. Blood 94: 127-138.
56. Henkel GW, McKercher SR, Maki RA (2002) Identification of three genes up-regulated in PU.1 rescued monocytic precursor cells. Int Immunol 14: 723-732.
57. Xu Y, Liu C, Clark JC, Whitsett JA (2006) Functional genomic responses to cystic fibrosis transmembrane conductance regulator (CFTR) and CFTR(delta508) in the lung. J Biol Chem 281: 11279-11291.
58. Hoefnagel JJ, Mulder MM, Dreef E, Jansen PM, Pals ST, et al. (2006) Expression of B-cell transcription factors in primary cutaneous B-cell lymphoma. Mod Pathol 19: 1270-1276.
59. Schoni MH, Schoni-Affolter F, Jeffery D, Katz S (1987) Intracellular free calcium levels in mononuclear cells of patients with cystic fibrosis and normal controls. Cell Calcium 8: 53-63.